
Michael Bouvet MD
Endocrine, Surgical Oncology (Other than Breast)
Surgical Oncology and Endocrine Surgery at UCSD
Join to View Full Profile
3855 Health Sciences DrUCSD Moores Cancer CenterLa Jolla, CA 92093
Phone+1 858-822-6191
Fax+1 858-249-0483
Dr. Bouvet is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Michael Bouvet, MD, is a general surgeon based in La Jolla, CA, with subspecialties in endocrine surgery and surgical oncology (excluding breast). He completed his surgery residency at the University of California (San Diego) Medical Center in 1995 and pursued a fellowship in Complex General Surgical Oncology at the University of Texas MD Anderson Cancer Center, finishing in 1998. Since 1998, he has served as a professor at the University of California San Diego School of Medicine. Dr. Bouvet has expertise in conditions such as papillary thyroid carcinoma, Graves' disease, hyperparathyroidism, adrenal surgery, and endocrine surgery. His published research primarily focuses on cancer diagnostics and treatment strategies. Clinically, he is involved in trials aimed at improving nerve visualization in head and neck surgery. His work has been recognized with several honors, including multiple certifications in CMS Meaningful Use and listings as one of America's Top Doctors by Castle Connolly.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 1998
University of California (San Diego) Medical CenterResidency, Surgery, 1995
University of Washington School of MedicineClass of 1989
Certifications & Licensure
CA State Medical License 1990 - 2026
TX State Medical License 1995 - 1999
American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2017
Clinical Trials
- Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery Start of enrollment: 2020 Jun 18
- Bevonescein for Intra-Operative Nerve Visualization in Head and Neck Surgery Start of enrollment: 2022 Apr 29
Publications & Presentations
PubMed
- Glutamine Dependence Is Not a Cancer-specific Vulnerability in Contrast to Methionine Dependence.Yuta Miyashi, Kohei Mizuta, Yohei Asano, Byung Mo Kang, Jin Soo Kim
Anticancer Research. 2026-02-01 - Lack of Cancer Specificity of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 in Combination With Recombinant Methioninase.Jinsoo Kim, Qinghong Han, Shukuan Li, Byung Mo Kang, Kohei Mizuta
Anticancer Research. 2026-02-01 - Methionine Restriction Must Be Continuously Maintained to Selectively Inhibit Cancer Cells Co-cultured With Normal Cells.Byung Mo Kang, Qinghong Han, Shukuan Li, Jin Soo Kim, Kohei Mizuta
Cancer Diagnosis & Prognosis. 2026-01-03
Press Mentions
Precision Reprogramming: How AI Tricks Cancer’s Toughest CellsOctober 20th, 2025- San Diego’s Top Doctors 2020: The ListOctober 28th, 2020
Anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule Antibody for Fluorescence VisualizationJanuary 31st, 2020
Grant Support
- BCCMA: VA Colorectal Cancer Clinical & Computational Collaborative (VA-5C): NIR-labeled antibodies to target and label colon polyps and cancer for improved diagnosis and surgeryVA SAN DIEGO HEALTHCARE SYSTEM2024–2028
- Targeting parathyroid glands with novel fluorophores for intraoperative imagingMASSACHUSETTS GENERAL HOSPITAL2017–2028
- Novel Tools for Colon Cancer Detection and TherapyOMAHA VA MEDICAL CENTER2023–2027
- Novel Tools for Colon Cancer Detection and TherapyOMAHA VA MEDICAL CENTER2023–2027
- Molecular Imaging Probe(s) for Optical Surgical Navigation of Pancreatic CancerUNIVERSITY OF CALIFORNIA, SAN DIEGO2022–2027
Professional Memberships
- Member
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









